AMRXのPER（株価収益率）は？

Amneal Pharmaceuticals, Inc. Class A Common Stock（AMRX）は現在PER 37.12倍で取引されています。

AMRXのROE（自己資本利益率）は？

Amneal Pharmaceuticals, Inc. Class A Common StockのROEは477.24%です。

AMRXの配当利回りは？

Amneal Pharmaceuticals, Inc. Class A Common Stockの配当利回りは0.00%です。

AMRXの品質スコア（Quality Score）は？

当社のAIはAMRXの総合財務品質を100点中38点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

AMRXは今が買い時ですか？

当社AIのタイミングスコアは100点中89点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

AMRXはどのセクターに属しますか？

Amneal Pharmaceuticals, Inc. Class A Common StockはHealthcare >> Drug Manufacturers - Specialty & Genericセクターに分類されます（NASDAQ市場）

AMRX (NASDAQ) 株価分析 | AMNEAL PHARMACEUTICALS, INC. CLASS A COMMON STOCK

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-03 | FS: 2026-06-30)

AMRX AI Analysis Summary

Our AI summary for AMRX: Amneal Pharmaceuticals, Inc. Class A Common Stock (NASDAQ), Healthcare >> Drug Manufacturers - Specialty & Generic sector. The stock currently trades at a P/E of 37.12, ROE of 477.24%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 89/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

AMRX

Amneal Pharmaceuticals, Inc. Class A Common Stock

USD 18.85

0.53 (2.89%) Day Change

Watchlist Portfolio Compare Chart

37.12

P/E

3.68

D/E

477.2%

ROE

4.2%

ROA

0.00%

Div Yield

-0.50

PEG

AMNEAL PHARMACEUTICALS, INC. CLASS A COMMON STOCK
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 18.85 Price 0.53 (2.89%) Day Change	NEWS SCORE: 96

AMRX, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) but テクニカルスコアは ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROEの伸びが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...

Deepscope 分析

50%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	96
Magic Formula Rank by ROA	2706
Magic Formula Rank by ROE	2706
Magic Formula Rank by ROIC	1641
Price	18.85
PBV / Sector	50.01 / 9.54
Earning Per Share	0.51

PE / Sector	37.12 / 28.71
PEG or PE/Growth / Sector	-0.50 / -0.10
Average 1M Daily Value	32.78 M GREAT
Average 1W Daily Value	39.43 M GREAT

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

37%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

60%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	5.06 / 15.25
NPM Average (%) / Sector	-1.23 / -10.83
NPM Change Average (%) / Sector	-16.58 / 117.82
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	4.17 / 8.18
ROA Average (%) / Sector	-0.61 / 2.87
ROA Change Average (%) / Sector	-9.23 / 113.04
ROE (%) / Sector	477.24 / 26.68 GREAT
ROE Average (%) / Sector	2.85 / 13.89
ROE Change Average (%) / Sector	-3.60 / 379.20
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.52
Dividend Average (%) / Sector	N/A / 3.06
Dividend Change Average (%) / Sector	N/A / 13.83

登録情報

Analyze Date	2026-08-04 08:01:08
Symbol	AMRX
Name	AMNEAL PHARMACEUTICALS, INC. CLASS A COMMON STOCK
Sector	Healthcare >> Drug Manufacturers - Specialty & Generic
Market	NASDAQ
Listed Shares	319.33 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	5,850.15 / 10,605.93

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 400 Crossing Boulevard, Bridgewater, NJ, United States, 08807

Phone: 908 947 3120

Website: https://www.amneal.com

Employees: 8,700

Sector: Healthcare >> Drug Manufacturers - Specialty & Generic

Description: Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in the United States, India, Ireland, and internationally. The company operates through three segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment offers dosage forms and delivery systems, which include immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, transdermal patches, and topicals. The Specialty segment develops, promotes, sells, and distributes pharmaceutical products with a focus on central nervous system and endocrine disorders, including Parkinson's disease. This segment provides Rytary, an oral capsule formulation of carbidopa-levodopa to treat Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism; Unithroid and ONGENTYS for the treatment of hypothyroidism; and CREXONT, which is use for the treatment of Parkinson's disease. The AvKARE segment offers pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. This segment also distributes bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names; and packages and distributes pharmaceuticals and vitamins to its retail and institutional customers. It sells its products through wholesalers, distributors, retail pharmacies, managed care organizations, purchasing co-ops, hospitals, government agencies, institutions, and pharmaceutical companies. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey.